Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
Top Cited Papers
- 15 June 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Virology
- Vol. 129, 104511
- https://doi.org/10.1016/j.jcv.2020.104511
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR TestingRadiology, 2020
- Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease PatientsEmerging Infectious Diseases, 2020
- Laboratory Diagnosis of COVID-19: Current Issues and ChallengesJournal of Clinical Microbiology, 2020
- Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2Journal of Clinical Microbiology, 2020
- In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging TrendsDiagnostics, 2020
- Developing antibody tests for SARS-CoV-2The Lancet, 2020
- Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesThe Lancet Infectious Diseases, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Laboratory diagnosis of emerging human coronavirus infections – the state of the artEmerging Microbes & Infections, 2020